- Home
- PHIO vs CMND Comparison
PHIO vs CMND Comparison
Compare PHIO & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- CMND
- Stock Information
- Founded
- PHIO 2011
- CMND 2017
- Country
- PHIO United States
- CMND Canada
- Employees
- PHIO N/A
- CMND N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- PHIO Health Care
- CMND Health Care
- Exchange
- PHIO Nasdaq
- CMND Nasdaq
- Market Cap
- PHIO 8.0M
- CMND 6.5M
- IPO Year
- PHIO N/A
- CMND N/A
- Fundamental
- Price
- PHIO $1.67
- CMND $1.29
- Analyst Decision
- PHIO Strong Buy
- CMND
- Analyst Count
- PHIO 1
- CMND 0
- Target Price
- PHIO $36.00
- CMND N/A
- AVG Volume (30 Days)
- PHIO 981.0K
- CMND 91.1K
- Earning Date
- PHIO 04-01-2025
- CMND 04-15-2025
- Dividend Yield
- PHIO N/A
- CMND N/A
- EPS Growth
- PHIO N/A
- CMND N/A
- EPS
- PHIO N/A
- CMND N/A
- Revenue
- PHIO N/A
- CMND N/A
- Revenue This Year
- PHIO N/A
- CMND N/A
- Revenue Next Year
- PHIO N/A
- CMND N/A
- P/E Ratio
- PHIO N/A
- CMND N/A
- Revenue Growth
- PHIO N/A
- CMND N/A
- 52 Week Low
- PHIO $1.53
- CMND $0.95
- 52 Week High
- PHIO $10.35
- CMND $2.30
- Technical
- Relative Strength Index (RSI)
- PHIO 42.10
- CMND 40.62
- Support Level
- PHIO $1.64
- CMND $1.35
- Resistance Level
- PHIO $1.88
- CMND $1.38
- Average True Range (ATR)
- PHIO 0.13
- CMND 0.09
- MACD
- PHIO -0.02
- CMND -0.01
- Stochastic Oscillator
- PHIO 5.61
- CMND 22.19
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.